Pachydaki SI - Search Results

1

The RAGE axis in early diabetic retinopathy.

Barile GR, Pachydaki SI, Tari SR, Lee SE, Donmoyer CM, Ma W, Rong LL, Buciarelli LG, Wendt T, Hörig H, Hudson BI, Qu W, Weinberg AD, Yan SF, Schmidt AM. Barile GR, et al. Among authors: pachydaki si. Invest Ophthalmol Vis Sci. 2005 Aug;46(8):2916-24. doi: 10.1167/iovs.04-1409. Invest Ophthalmol Vis Sci. 2005. PMID: 16043866 Free article.

2

Upregulation of RAGE and its ligands in proliferative retinal disease.

Pachydaki SI, Tari SR, Lee SE, Ma W, Tseng JJ, Sosunov AA, Cataldergirmen G, Scarmeas N, Caspersen C, Chang S, Schiff WM, Schmidt AM, Barile GR. Pachydaki SI, et al. Exp Eye Res. 2006 May;82(5):807-15. doi: 10.1016/j.exer.2005.09.022. Epub 2005 Dec 20. Exp Eye Res. 2006. PMID: 16364297

3

RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-alpha and NF-kappaB.

Cataldegirmen G, Zeng S, Feirt N, Ippagunta N, Dun H, Qu W, Lu Y, Rong LL, Hofmann MA, Kislinger T, Pachydaki SI, Jenkins DG, Weinberg A, Lefkowitch J, Rogiers X, Yan SF, Schmidt AM, Emond JC. Cataldegirmen G, et al. Among authors: pachydaki si. J Exp Med. 2005 Feb 7;201(3):473-84. doi: 10.1084/jem.20040934. J Exp Med. 2005. PMID: 15699076 Free PMC article.

4

RAGE modulates peripheral nerve regeneration via recruitment of both inflammatory and axonal outgrowth pathways.

Rong LL, Yan SF, Wendt T, Hans D, Pachydaki S, Bucciarelli LG, Adebayo A, Qu W, Lu Y, Kostov K, Lalla E, Yan SD, Gooch C, Szabolcs M, Trojaborg W, Hays AP, Schmidt AM. Rong LL, et al. FASEB J. 2004 Dec;18(15):1818-25. doi: 10.1096/fj.04-1900com. FASEB J. 2004. PMID: 15576485

5

Mechanisms for the induction of HNE- MDA- and AGE-adducts, RAGE and VEGF in retinal pigment epithelial cells.

Zhou J, Cai B, Jang YP, Pachydaki S, Schmidt AM, Sparrow JR. Zhou J, et al. Exp Eye Res. 2005 Apr;80(4):567-80. doi: 10.1016/j.exer.2004.11.009. Exp Eye Res. 2005. PMID: 15781285

6

Apoptosis and cell proliferation in proliferative retinal disorders: PCNA, Ki-67, caspase-3, and PARP expression.

Zhang X, Barile G, Chang S, Hays A, Pachydaki S, Schiff W, Sparrow J. Zhang X, et al. Curr Eye Res. 2005 May;30(5):395-403. doi: 10.1080/02713680590956306. Curr Eye Res. 2005. PMID: 16020270

7

The prevalence and incidence of epiretinal membranes in eyes with inactive extramacular CMV retinitis.

Kozak I, Vaidya V, Van Natta ML, Pak JW, May KP, Thorne JE; Studies of the Ocular Complications of AIDS Research Group. Kozak I, et al. Invest Ophthalmol Vis Sci. 2014 Jun 12;55(7):4304-12. doi: 10.1167/iovs.14-14479. Invest Ophthalmol Vis Sci. 2014. PMID: 24925880 Free PMC article.

8

Comparison of treatment regimens for cytomegalovirus retinitis in patients with AIDS in the era of highly active antiretroviral therapy.

Jabs DA, Ahuja A, Van Natta M, Dunn JP, Yeh S; Studies of the Ocular Complications of AIDS Research Group. Jabs DA, et al. Ophthalmology. 2013 Jun;120(6):1262-70. doi: 10.1016/j.ophtha.2012.11.023. Epub 2013 Feb 16. Ophthalmology. 2013. PMID: 23419804 Free PMC article.

9

Phenotypic features of patients with NR2E3 mutations.

Pachydaki SI, Klaver CC, Barbazetto IA, Roy MS, Gouras P, Allikmets R, Yannuzzi LA. Pachydaki SI, et al. Arch Ophthalmol. 2009 Jan;127(1):71-5. doi: 10.1001/archophthalmol.2008.534. Arch Ophthalmol. 2009. PMID: 19139342

10

Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes.

Jabs DA, Ahuja A, Van Natta M, Lyon A, Srivastava S, Gangaputra S; Studies of the Ocular Complications of AIDS Research Group. Jabs DA, et al. Ophthalmology. 2010 Nov;117(11):2152-61.e1-2. doi: 10.1016/j.ophtha.2010.03.031. Epub 2010 Jul 29. Ophthalmology. 2010. PMID: 20673591 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page